When investigating health effects of oral contraceptive (OC) use, women are usually interviewed to obtain information on their use of OC in the past. But if women tend to forget and underreport their OC use, the results from such studies are biased. A non-differential misdassification will usually bias relative risks towards RR = 1. However, in studies where women are interviewed only after the cases have appeared, the experience of disease among the cases may enhance their recall and reporting of OC use, resulting in overestimation of relative risks. For instance, a case-referent study of OC use and breast cancer may show an excess risk-even in the absence of any effect-if cases are more likely than referents to recall and report their past use of OC. This source of bias has been discussed as a possible explanation for associations found, for instance, between OC use and breast cancer. 1 Previous studies have shown surprisingly high levels of agreement between interview data and medical records, both for time since first and last use of OC 2 and for total duration of use. 2 " 6 However, three of these studies only included women who had been using OC according to interviews. 2 ' 4 ' 5 In addition, 30-50% of the women in these studies were lost due to failure to obtain usable information from the records. TVvo studies
The purpose of the present study is to compare the information on lifetime OC use obtained by a structured interview to that obtained from a register of pharmacy records, in a geographically defined population of young Swedish women. In particular, there is an interest in the extent to which women tend to underreport their past OC use by interview, and in the possible bias introduced by such underreporting.
Women and Methods
Since 1970, there is a continuous recording of outpatient prescriptions dispensed by pharmacies in the county of Jamtland for 17 600 subjects or 13% of the population of the county (all subjects bom on the same 4 days in each month). The information recorded includes a unique personal identification number (providing information on sex and birth date for each subject), dispensing pharmacy and date, and the name, strength, quantity and dosage of each drug dispensed. The subjects and methods are described in detail elsewhere. 7 For the present study we selected all women included in this register who were aged 20-34 years and, according to census lists, had been residing in the central part of the county since 1970.
The procedures used to obtain interview data on OC use followed those applied in a joint national case-referent study in Sweden and Norway, on OC use and breast cancer in young women. 8 Thus, women were contacted by mail and telephone to inform them about the study and select a day for the interview at their convenience. Interviews were conducted in the women's homes from October through December 1990, by eight experienced health interviewers trained for the present study during a run-in period. The interview followed a structured questionnaire on social background and reproductive and contraceptive histories. In order to facilitate recall of contraceptive history, a calendar was used to record life events such as menarche, marriage, divorce, childbirth and lactation. The history of contraceptive use was then related to the life events. Furthermore, pictures of packages for all OC that had been available since 1964, together with information on the time period of their registration on the market, were shown to aid recall. These procedures, using a life event calendar and picture display, have been used in subsequent studies. 9 ' 10 For each woman, information on her OC use from the interview was compared to the corresponding information from her file in the register of pharmacy records. In the analysis, register data were treated as if an OC was used from the time it was dispensed. Comparisons were made with regard to current and past use of OC. When studying the health effects of OC use, the induction time is often unknown and may vary considerably between different diseases. Thus, there is often an interest in OC use in different 'time windows' in the past. 11 In the present study, comparisons were made with regard to current OC use as well as OC use within 5 years, between 5 and 10 years, and 10 or more years prior to the time of the interview. In addition, comparisons were made for total duration of OC use, as well as time since first use, and time since last use of OC. As a measure of agreement between interview and register data we used a correlation coefficient. 12 In one analysis, OC were subdivided according to their oestrogen contents: 'high dose' (>50 |ig of ethinyloestradiol or mesteranol), 'low dose' (=550 ug of oestrogen), and so-called mini-pills (progestogen-only pills). Basically, high-dose pills were those available on the market from the 1960s through the early 1970s, whereas the modem low-dose pills became predominant on the market from the mid 1970s. The study was approved by the Ethics Committee of the University Hospital of Ume3.
Results
A total of 540 women aged 20-34 were identified in the register, but 29 of these women were excluded because they did not live in the county at the time of the interviews. Of the remaining 511 women, 84 (16%) did not participate in the interviews: 77 because they refused, five because of illness, and two women could not be contacted. Thus, 427 women provided interview data on OC use to be compared with their records in the register. The women lost were found to be similar to those who participated in the interviews with regard to age, domicile (degree of urbanization) and pharmacy records (OC prescriptions dispensed).
Information on current OC use is shown in Table 1 . For 24% (37/153) of the women who were current users according to the interview, their last prescription dispensed would not last until the interview. But only 1.5% (4/274) of the women who were not current users according to the interview, had a prescription dispensed that would cover the time of the interview. The total duration of OC use is shown in Table 2 . Of the women identified as never-users by interview, 5% (2/37) had records of OC prescriptions dispensed (for <2 years' use). Of the 36 women identified as never-users by their pharmacy records, only one had used OC according to the interview (for <2 years). When compared with the pharmacy records, there was no general tendency for women to underreport their OC use in the interviews: 13% reported a shorter and 28% a longer duration of OC use than indicated by the records. But, as shown in Table 2 , the difference in duration was usually modest. The correlation coefficient was 0.78. The duration of use was, on average, 9% longer based on interviews than on records. In a separate analysis we excluded women who, according to the interview, sometimes had their OC dispensed outside the county when travelling or during vacation. This reduced the difference in average duration from 9% to 6%.
In Table 3 , interviews and pharmacy records are compared with regard to OC use in different 'time windows' prior to the time of the interview: within 5 years (A), 5-10 years (B), and s»10 years (C) before the time of the interview. For each of these three periods, 2.6% (8/312), 4.6% (14/307) and 12.8% (26/203), respectively, of the women identified as users by interview had no presdpn'ons dispensed for that period. But most of these women reported less than one year's use during the period. Of the women identified as users by the records, 7.6% (25/329), 5.5% (17/310) and 3.8% (7/184), respectively, had not used OC during the period according to the interviews. But most of these women had prescriptions that would last for less than one year during the period. When comparing the two sources of information with regard to duration of OC use within each of the three time periods (A, B and C), the correlation coefficient was 0.82, 0.71 and 0.74, respectively.
Time since first use and time since last use of OC is shown in Tables 4 and 5 , respectively. The comparison between interviews and pharmacy records showed that any differences in time were usually modest: the correlation coefficient was 0.93 for time since first use, and 0.84 for time since last use. But when compared to the pharmacy records, the time since first use according to interviews was longer for 34% (132/389) and shorter for 7% (28/389) among women who ever used OC according to both sources of information. The difference was, however, usually <2 years. Similarly, when compared to the pharmacy records, the time since last use according to interviews was longer for 26% (61/232) and shorter for 4% (9/232) among women with past use of OC according to both sources of information. But the difference was usually <2 years. Table 6 shows ever use by type of OC. The agreement between interviews and records for any OC was higher than that for specific types of OC. In particular, the proportion who did not recall the type of OC dispensed by the pharmacy was 19% (24/124) for high dose OC, 8% (31/379) for low dose OC, and 33% (26/80) for mini-pills.
Discussion
The present study was initiated against the background of expectations that women may tend to forget and underreport their past use of OC. But, when compared with the register of pharmacy records, we found no general tendency for women to underreport their OC use in interviews. On the contrary, there was a tendency for women to report a somewhat longer duration of OC use than that suggested by the pharmacy records (Tables 2 and 3 ). This could be due to women having some of their OC dispensed by pharmacies outside the county (not covered by the register). In the interviews, the women were asked if they sometimes had their OC dispensed by pharmacies outside the county, for instance when travelling or during vacation. In a separate analysis, based on those women who said they only received OC from pharmacies in the county, the difference in duration of OC use between interviews and records was reduced but did not disappear. Another possible explanation is incomplete registration of prescriptions dispensed by pharmacies in the county. But since the start in 1970, the registration of prescriptions has been checked and found to be virtually complete. 7 With complete registration, our findings suggest that the duration of OC use was slightly overestimated from the interviews. In these interviews, women were asked to recall the dates for the beginning and end of each period of OC use-and the duration of use was calculated from these dates. As shown for the first period of OC use in Table 4 , when the recorded date of the first prescription dispensed was 3>4 years ' NC = Never used or currently using oral contraceptives.
prior to the interview, women tend to recall the time since Erst use as being one or two years longer than that recorded. Similarly, as shown in Table 5 , there was a tendency for women to recall the time since last use as being somewhat longer than that estimated from the records. But, when estimating the duration of use, the reporting error for first and last use will not cancel since many women were still using OC at the time of the interview (or had stopped only recently). The difference was sufficient to explain the tendency to overestimate the duration of OC use from interview data in the present study.
Of the women identified as current OC users by interview, 24% had an interval since their last prescription was dispensed that was longer (usually by a couple of months) than the time these OC would last. A likely explanation is that these women were current users who had some OC left from prescriptions dispensed previously, whereas overreporting of current OC use seems to be a less likely explanation. Of the women not identified as current users by interview, only 1.5% had a prescription dispensed that would cover the time of the interview. At least some of these women may not yet have started to take their OC at the time of the interview. Thus, the findings suggest that there was little or no underreporting of current OC use in the interviews.
Previous studies, including women selected in different ways, have shown high levels of agreement between questionnaire data and medical records for current OC use, 3 age at Erst use, 13 times since first and last use 2 and total duration of use, 2 " 6 but lower levels of agreement for specific OC brands used in the past.
The agreement has been found to be improved by the use of a contraceptive calendar at the interviews. 6 In studies where cases and referents have been compared, the agreement was similar for cases and referents in one study 2 while the agreement was somewhat better for cases than for referents in two studies. 4 ' 5 In a case-referent study of malignant melanoma, the relative risk (ever versus never use) based on questionnaire data on OC use was similar to that based on general practitioner records. 14 With regard to past OC use, the consequences of using interview data rather than register data will, of course, depend upon the purpose and design of a study as well as the categories used for classification of subjects according to OC use. When investigating possible health effects of OC use, a non-differential misdassification of the magnitude indicated by the findings of the present study is likely to introduce only a modest bias towards RR = 1. For example, using the data in Table 2 , a true relative risk (any versus no OC use) of 2.00 based on pharmacy records would be estimated at 1.90 using interview data. The bias is likely to be even less, because the misclassified women had low levels of exposure (<2 years' use, Table 2 ). The two women classified as unexposed only by interview may even have been unexposed (i.e. not used the OC dispensed), and the woman classified as exposed only by interview may have been exposed (having her OC dispensed outside the county). Using a classification from the joint national study, 8 non-differential exposure misdassification would also be modest: our interviews identified 115 women as highly exposed (>8 years' use) and all of them were dassified as exposed by their pharmacy records: 74 for >8 years, 26 for 6-8 years, 12 for 4-6 years, and 3 for <4 years ( Table 2 ).
The possibility of a differential exposure misdassification is usually considered as a more serious threat to validity, particularly in studies where information on past OC use is obtained by interview only after the cases have appeared. In such studies, a tendency to underreport OC use among noncases, but not among the cases, would result in overestimation of relative risks. For instance, suppose that all cases would recall and report any OC use recorded in the register or by interview (or both), while the non-cases would still report their OC use as in the interviews. With this rather extreme assumption, using the data in Table 2 and a simple subdivision into exposed (any OC use) and unexposed, a relative risk of 1.00 would be estimated at 1.06. Using a dassification from the joint national study, with highly exposed (>8 years' use) and unexposed women (never used), a relative risk of 1.00 would be estimated at 1.13. When considering duration of OC use, differential exposure misdassification is unlikely to result in more than a modest overestimation of relative risks unless the cases would tend to report OC use that, in the present study, was neither reported by interview nor recorded in the register of pharmacy records.
With regard to specific kinds of OC (Table 6) , there was more often disagreement between interviews and pharmacy records.
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This may be due to difficulties in recalling the specific brands of OC used in the past, even with the memory aids used in our interviews. For instance, of the women who had ever used high dose OC according to their record, 19% (24/124) did not recall and report the name of any such brand in the interview. Using the same extreme assumption as above, a relative risk of 1.00 for any use of high dose OC would be estimated at 1.29 due to differential exposure misdassification.
In conclusion, when compared with the pharmacy records, women did not tend to underreport their past OC use in the interviews. For time since first use, time since last use, and duration of OC use, interview data and pharmacy records showed high levels of agreement. While some discrepancies are due to inaccurate recall, others may be due to failure of the records to reflect actual intake of OC. When studying health effects of OC use, any bias due to the lack of agreement would usually be modest. This applies to non-differential exposure misdassification as well as to the magnitude of the 'recall bias' introduced in a case-referent study where cases have a better recall than referents of their past OC use. For current OC use, interviews may be a more useful and accurate source of information than pharmacy records. When considering different kinds of OC used in the past, difficulties in recalling spedfic brands will favour the use of pharmacy records.
The extent to which our findings will apply in other settings will, of course, depend upon the methods used and the women induded in a study. For the interviews we used some spedfic aids, induding a life event calendar and picture display, and the findings of the present study may not apply to other ways of obtaining interview data on OC use. In addition, there are likely to be differences between different populations of women as regards the accuracy of interview data on OC use. Swedish women aged 20-34, selected for the present study, are not likely to be influenced by 'sodal desirability' or other judgemental aspects of OC use. Our findings may not apply to older women (with a much longer time elapsed since their use of OC) or to women with a different cultural background. Pharmacy records were obtained from a representative sample of women living in a community but, to cover the time since 1970, women who had moved in later were not induded. Of the women selected, 16% did not partidpate in the interviews. A similar non-partidpation in the interviews could be expected in an epidemiological study using interview data. Thus, our findings are likely to apply to interview data (using a certain method) from young women in a similar population partidpating in an epidemiological study.
